Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:15 pm Unchanged |
2023-12-31 | 13G | Marpai, Inc. MRAI |
Altium Capital Management LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-13 5:10 pm Purchase |
2023-12-31 | 13G | Xtant Medical Holdings, Inc. XTNT |
Altium Capital Management LLC | 8,027,593 6.200% |
1,529,675 (+23.54%) |
Filing History |
| 2024-02-13 3:47 pm Unchanged |
2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Altium Capital Management LLC | 194,100 4.990% |
0 (Unchanged) |
Filing History |
| 2024-02-13 3:27 pm Sale |
2023-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Altium Capital Management LLC | 2,660,000 5.000% |
-324,803 (-10.88%) |
Filing History |
| 2024-02-02 6:09 pm Purchase |
2024-01-29 | 13G | Skye Bioscience, Inc. SKYE |
Altium Capital Management LLC | 1,301,518 5.400% |
1,301,518 (New Position) |
Filing History |
| 2024-01-10 1:35 pm Purchase |
2023-12-21 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Altium Capital Management LLC | 194,100 8.000% |
194,100 (New Position) |
Filing History |
| 2023-11-22 5:31 pm Purchase |
2023-11-16 | 13G | Volcon, Inc. VLCN |
Altium Capital Management LLC | 78 9.900% |
78 (New Position) |
Filing History |
| 2023-08-23 06:01 am Purchase |
2023-08-15 | 13G | Alimera Sciences, Inc. ALIM |
Altium Capital Management LLC | 2,984,803 5.700% |
2,984,803 (New Position) |
Filing History |
| 2023-05-02 8:23 pm Purchase |
2023-04-24 | 13G | GRI Bio, Inc. GRI |
Altium Capital Management LLC | 820 9.990% |
820 (New Position) |
Filing History |
| 2023-04-26 5:18 pm Purchase |
2023-04-17 | 13G | Marpai, Inc. MRAI |
Altium Capital Management LLC | 451,332 6.200% |
451,332 (New Position) |
Filing History |
| 2023-02-14 4:51 pm Unchanged |
2022-12-31 | 13G | Xtant Medical Holdings, Inc. XTNT |
Altium Capital Management LLC | 6,497,918 5.700% |
0 (Unchanged) |
Filing History |
| 2023-02-14 3:59 pm Unchanged |
2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Altium Capital Management LLC | 1,355,372 4.950% |
0 (Unchanged) |
Filing History |
| 2023-02-14 2:44 pm Sale |
2022-12-31 | 13G | HyreCar Inc. HYREQ |
Altium Capital Management LLC | 1,688,120 5.600% |
-48,795 (-2.81%) |
Filing History |
| 2023-02-14 2:35 pm Unchanged |
2022-12-31 | 13G | Sadot Group Inc. SDOT |
Altium Capital Management LLC | 288,809 4.990% |
0 (Unchanged) |
Filing History |
| 2023-02-14 12:35 pm Sale |
2022-12-31 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO |
Altium Capital Management LLC | 0 0.000% |
-41,667 (Position Closed) |
Filing History |
| 2023-02-14 12:26 pm Unchanged |
2022-12-31 | 13G | Palisade Bio, Inc. PALI |
Altium Capital Management LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-12-21 2:12 pm Purchase |
2022-12-15 | 13G | Astria Therapeutics, Inc. ATXS |
Altium Capital Management LLC | 1,355,372 5.200% |
1,355,372 (New Position) |
Filing History |
| 2022-11-17 5:08 pm Purchase |
2022-11-04 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO |
Altium Capital Management LLC | 41,667 7.700% |
41,667 (New Position) |
Filing History |
| 2022-11-08 7:44 pm Purchase |
2022-09-02 | 13G | HyreCar Inc. HYREQ |
Altium Capital Management LLC | 1,736,915 5.800% |
1,736,915 (New Position) |
Filing History |
| 2022-02-14 3:09 pm Sale |
2022-02-02 | 13G | Palisade Bio, Inc. PALI |
Altium Capital Management LLC | 4,467 9.990% |
-859 (-16.13%) |
Filing History |